DMPSi-Pd/SiO2500mg

Methyl 2-(piperidin-4-yl)thiazole-4-carboxylate, 98%, 1g

4,6-Dichloro-2-(methylthio)pyrimidine-5-carbaldehyde, 97.0%, 5g

Methyl 5-chloro-3-hydroxythiophene-2-carboxylate, 95.0%, 1g

Pyronin G (CI 45005), puro, 10 g, confezione in vetro

6-(4-methoxyphenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxylic acid, 95.0%, 500mg

4,4'-(5'-(4-(Pyridin-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)dipyridine, 97%, 500mg

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 1mg

5-Hydroxyflavone, 98.0%, 100mg

(1H-Imidazol-2-yl)boronic acid, 97%, 250mg

4-Benzyl 1-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate, 97%, 100mg

Benzene-1,2,4-triamine dihydrochloride, 96.0%, 5g

Colonna capillare per GC ROTI®Cap-5, 50 m, 0.32 mm, 3.00 µm, 1 Pezzo(i)